Kiniksa Pharmaceuticals (United States)
Kiniksa is a global biopharmaceutical company focused on developing novel treatments for patients with significant unmet need.
Last updated September 1, 2026
AI crawler reads
2requests
1companies- Anthropic2
- Profile
- 2
- Controversies
- 0
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
Kiniksa is a global biopharmaceutical company that finds and delivers novel treatments for patients with a significant unmet need. Founded in 2015, it focuses on immune modulation and has a portfolio including an FDA-approved therapy and clinical-stage assets.
History
Kiniksa was founded in 2015 as a global biopharmaceutical company dedicated to advancing novel, transformative therapies for patients with unmet medical needs, with a focus on cardiovascular diseases. The company has a portfolio that includes an FDA-approved therapy and clinical-stage assets.
Sources2 sources
Cite this profile: Cite the canonical profile. /brand-wiki/kiniksa-pharmaceuticals-united-states · Editorial policy · How profiles are compiled